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Autoimmune hemolytic anemia associated
with babesiosis
Roshni Narurkar, Aleksandra Mamorska-Dyga, John C. Nelson and Delong Liu*
Abstract
Background: Babesiosis is endemic in selected areas in North America. Babesia infection is commonly associated
with anemia, thrombocytopenia, hyponatremia and elevated liver enzymes. Autoimmune hemolytic anemia (AIHA)
is known to be caused by parasitic and viral infections but has not been well characterized.
Case presentation: We describe two cases diagnosed with babesiosis triggering severe AIHA. One case had history
of splenectomy, and the other was an elderly patient. Older, immunocompromised and asplenic patients may be
particularly at risk for post-babesiosis AIHA (PB-AIHA).
Conclusions: The pathogenesis for conventional AIHA and PB-AIHA appears to be different, since splenectomy is a
treatment for conventional AIHA, whereas PB-AIHA is seen more often in asplenic patients. Further investigation
into this intriguing mechanism of host immune response to babesiosis may help to elucidate the overall
mechanism of infection- triggered AIHA.
Background
Human babesiosis was first reported in 1957 [1, 2].
Babesia divergens is common in Europe, while babesia
microti is more commonly seen in North America [3]. In
the Unites States 97% of the reported cases came from
seven North-East states, occurring predominantly in the
months of June–August [4, 5]. According to the CDC
data, 1744 cases of babesiosis were identified in 2014, with
almost all of them diagnosed in the Northeastern United
States and New England. Babesia microti is spread in
nature by ixodes scapularis ticks (also called blacklegged
ticks or deer ticks). Babesia infection may vary from an
asymptomatic course to a life-threatening disease [4, 6, 7].
Immunocompromised and asplenic patients are especially
susceptible to serious illnesses. Common laboratory
findings include hemolytic anemia, thrombocytopenia,
hyponatremia and elevated liver enzymes [8–12].
Autoimmune hemolytic anemia (AIHA) is characterized
by shortened red blood cell (RBC) survival and presence
of auto-antibodies with a positive direct antiglobulin test
(DAT) [13, 14]. DAT detects immunoglobulin and/or
complement C3d against autologous RBCs [15]. The
binding pattern is suggestive of specific etiologies. For
example, IgG alone or IgG and C3d binding is seen in
warm AIHA and drug induced anemias, as opposed to C3d
alone, which is seen in cold agglutinin disease. AIHA can
be idiopathic or secondary to lymphoproliferative disorders,
malignancies, autoimmune disorders and infections. Lym-
phoproliferative disorders are the most common causes of
both types of AIHA. Autoimmune diseases are associated
with warm AIHA, while infections cause cold AIHA [16].
AIHA is known to be caused by parasitic and viral infec-
tions. Here, we report 2 cases of babesiosis complicated
with severe warm autoimmune hemolytic anemia.
Case presentation
Case 1
A 43 year old male had history of hemophagocytic
lymphohistiocytosis (HLH) 9 years ago who had
splenectomy at that time. The patient was admitted to
an outside hospital with complaints of persistent fever,
malaise, nausea and vomiting. He was diagnosed with
babesiosis and ehrlichiosis [17, 18]. He was treated with
antibiotics including IV azithromycin, doxycycline and
atovaquone for babesiosis and ehrlichiosis [18–21]. He
was discharged home on oral antibiotics [22].
Shortly after the discharge, he presented with dark
urine to the local hospital with laboratory findings
suggestive of hemolytic anemia. He was then transferred
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to our institution. Upon admission laboratory values
were significant for total bilirubin of 5.4 mg/dL, (direct
bilirubin of 0.6 mg/dL), white blood cell count (WBC) of
16.9 × 103/mm3 (30% neutrophils, 53% lymphocytes,
and 15% monocytes), reticulocyte count of 13%, lactate
dehydrogenase (LDH) level of 884 U/L and haptoglobin
measured as <8 mg/dL. Ferritin level was 4527 μg/L,
triglyceride 265 mg/dL. We performed bone marrow
aspiration and biopsy, which revealed trilineage hema-
topoiesis with erythroid hyperplasia, as well as presence of
Babesia species in mature erythrocytes (1–2%). Immunohis-
tochemistry stains demonstrated CD163 positive macro-
phages engulfing erythrocytes and neutrophils, consistent
with hemophagocytosis [23, 24]. Patient was started on
chemotherapy for HLH with etoposide and steroids with
overall improvement in laboratory values and clinical condi-
tion. He also continued to receive antibiotics for treatment
of babesiosis with reduction and eventual clearance of blood
parasitemia. The hospital course was complicated by deep
vein thrombosis in lower extremity, for which patient was
treated with heparin and warfarin. One week post discharge,
he was again admitted to our hospital with complaints of
vomiting, nausea and discoloration of urine. Laboratory
data on second admission was significant for total bilirubin
of 6.3 mg/dL (direct bilirubin of 0.6 mg/dL), LDH of
408 U/L and haptoglobin <8 mg/dL. Ferritin level was
4205 μg/L, triglyceride 373 mg/dL. Pathology from bone
marrow aspiration and biopsy at this admission revealed
hypocellular bone marrow with trilineage hematopoiesis,
marginally increased monocytes/histiocytes and rare
hemophagocytosis. Direct antiglobulin test (DAT) was
positive (IgG and polyclonal, negative previously). Testing
for paroxysmal nocturnal hemoglobinuria, cryoglobuline-
mia, glucose-6-phosphate dehydrogenase (G6PD) defi-
ciency and hyperhomocystinemia was negative. Patient
was maintained on methylprednisolone for AIHA. Blood
parasite smear was negative for blood parasites, but
babesia microti DNA PCR was persistently positive
[25, 26], for which patient was continued on antibiotics.
His overall status improved and patient was discharged
home with oral antibiotics and prednisone. Prednisone
was tapered to off over the following 6 weeks. The patient
has not had recurrence of hemolysis for 14 months.
Case 2
An 81 year old female with multiple medical conditions
including non-obstructive coronary artery disease,
hypertension and chronic bronchitis presented to an
outside hospital with complaints of progressive fatigue,
shortness of breath, associated with chills and diaphor-
esis. Immediately prior to admission she noticed yellow
discoloration of the skin. The patient recalled history of
a tick bite 1 month earlier, which was removed without
residual skin rash. In the outside institution she was
diagnosed with babesiosis, as well as acute kidney injury,
liver insufficiency and non-ST elevation myocardial in-
farction. She was started on antibiotics and transferred
to our hospital. Upon admission laboratory studies were
significant for WBC of 7 × 103/mm3, hemoglobin of
9.1 g/dL, platelet count of 54 × 103/mm3, creatinine of
3.56 mg/dL, LDH 2161 U/L, aspartate transaminase
(AST) of 271 U/L and alanine transaminase (ALT) of
143 U/L. Total bilirubin was 3.6 mg/dL (with direct
bilirubin of 1.8 mg/dL) and haptoglobin was <8 mg/dL.
Peripheral blood smear was positive for babesiosis with
parasitemia of <1%. In the following days a decline in
hemoglobin was noted to the lowest value of 6.5 g/dL.
DAT was positive (IgG and polyclonal). The anemia was
therefore consistent with AIHA. Patient’s renal function
and respiratory status further deteriorated. She was intu-
bated for acute respiratory distress syndrome and started
on hemodialysis. She also received vasopressor support
for a brief period of time. Patient underwent one session
of plasmapheresis for severe AIHA. Blood parasitemia
cleared but hemoglobin levels remained low despite trans-
fusion of multiple units of cross-matched packed red
blood cells. The patient’s status continued to deteriorate
with progressive multiorgan failure leading to the decision
of withdrawal of care. The patient subsequently expired.
Discussion
This study reported two cases of severe AIHA associated
with babesiosis. The babesiosis- associated AIHA re-
mains rare, even though anemia is commonly seen in
babesia infections [11, 27]. Although unlikely, it remains
unclear whether erlichiosis had any role in triggering
AIHA in the first case. AIHA has been reported in a
variety of parasite infections. AIHA has been reported to
be associated with acute malaria infection [28, 29].
Leishmania species causing Kala-azar disease is another
intracellular parasite associated with DAT positive
hemolytic anemia [30]. Viral infections including influ-
enza virus, hepatitis virus, cytomegalovirus, Epstein-Barr
virus have been implicated in AIHA [31]. Farwell et al.
described Coombs positive anemia in dogs infected with
Babesia gibsoni and Babesia canis [32]. Post transfusion
babesiosis with a DAT positive hemolytic anemia has
also been reported [33, 34]. It is important to consider
blood parasite infections as a probable cause of hemo-
globinuria and warm AIHA [15, 16]. AIHA was recently
reported in 7% of all patients with babesia infection in a
series, but close to 30% in asplenic patients [35]. The
mechanism for post-babesiosis AIHA (PB-AIHA) was
proposed to be related to antibody-mediated and
immune-complex- mediated hypersensitivity. However,
there is clear difference in the pathogenesis for conven-
tional AIHA and PB-AIHA, since splenectomy is a treat-
ment for conventional AIHA, whereas PB-AIHA is seen
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more often in asplenic patients. Further investigation
into this intriguing mechanism of host immune response
to babesiosis may help to elucidate the overall mechan-
ism of infection- triggered AIHA.
Conclusions
Severe AIHA may be triggered by babesiosis. Older and
asplenic patients may be particularly at risk for post-
babesiosis AIHA.
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